These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1609472)

  • 21. Atypical myxomatosis--virus isolation, experimental infection of rabbits and restriction endonuclease analysis of the isolate.
    Psikal I; Smíd B; Rodák L; Valícek L; Bendová J
    J Vet Med B Infect Dis Vet Public Health; 2003 Aug; 50(6):259-64. PubMed ID: 14628995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of serological evidence of myxoma virus infection in humans exposed during an outbreak of myxomatosis.
    Jackson EW; Dorn CR; Saito JK; McKercher DG
    Nature; 1966 Jul; 211(5046):313-4. PubMed ID: 4381646
    [No Abstract]   [Full Text] [Related]  

  • 23. Occurrence of atypical myxomatosis in Central Europe: clinical and virological examinations.
    Farsang A; Makranszki L; Dobos-Kovács M; Virág G; Fábián K; Barna T; Kulcsár G; Kucsera L; Vetési F
    Acta Vet Hung; 2003; 51(4):493-501. PubMed ID: 14680061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The current status and future directions of myxoma virus, a master in immune evasion.
    Spiesschaert B; McFadden G; Hermans K; Nauwynck H; Van de Walle GR
    Vet Res; 2011 Jun; 42(1):76. PubMed ID: 21658227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myxomatosis: the occurrence of antibody to a soluble antigen of myxoma virus in wild rabbits, Oryctolagus cuniculus (L.), in Victoria, Australia.
    Edmonds JW; Shepherd RC; Nolan IF
    J Hyg (Lond); 1978 Oct; 81(2):245-9. PubMed ID: 701788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Restriction by polycations of infection with myxoma virus in rabbits.
    Wegner DL; Hinze HC
    J Infect Dis; 1972 Feb; 125(2):141-5. PubMed ID: 4550228
    [No Abstract]   [Full Text] [Related]  

  • 27. Monitoring the spread of myxoma virus in rabbit Oryctolagus cuniculus populations on the southern tablelands of New South Wales, Australia. I. Natural occurrence of myxomatosis.
    Merchant JC; Kerr PJ; Simms NG; Robinson AJ
    Epidemiol Infect; 2003 Feb; 130(1):113-21. PubMed ID: 12613753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation of an attenuated myxoma virus field strain that can confer protection against myxomatosis on contacts of vaccinates.
    Bárcena J; Pagès-Manté A; March R; Morales M; Ramírez MA; Sánchez-Vizcaíno JM; Torres JM
    Arch Virol; 2000; 145(4):759-71. PubMed ID: 10893154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genome sequence of SG33 strain and recombination between wild-type and vaccine myxoma viruses.
    Camus-Bouclainville C; Gretillat M; Py R; Gelfi J; Guérin JL; Bertagnoli S
    Emerg Infect Dis; 2011 Apr; 17(4):633-8. PubMed ID: 21470452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myxomatosis on the Western Plains of Victoria.
    Tighe FG; Edmonds JW; Nolan IF; Shepherd RC; Gocs A
    J Hyg (Lond); 1977 Oct; 79(2):209-17. PubMed ID: 20473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo inhibition of myxoma virus by treatment with phosphonoacetic acid.
    Goodrich JM; Lee KW; Hinze HC
    Arch Virol; 1981; 70(2):157-64. PubMed ID: 7332492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ATTENUATION OF THE MYXOMA VIRUS AND USE OF THE LIVING ATTENUATED VIRUS AS AN IMMUNIZING AGENT FOR MYXOMATOSIS.
    SAITO JK; MCKERCHER DG; CASTRUCCI G
    J Infect Dis; 1964 Dec; 114():417-28. PubMed ID: 14233132
    [No Abstract]   [Full Text] [Related]  

  • 33. Immune responses to myxoma virus.
    Kerr P; McFadden G
    Viral Immunol; 2002; 15(2):229-46. PubMed ID: 12081009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluctuations in the titre of antibody to a soluble antigen of myxoma virus in field populations of rabbits, Oryctolagus cuniculus (L.), in Australia.
    Williams RT; Dunsmore JD; Sobey WR
    J Hyg (Lond); 1973 Sep; 71(3):487-500. PubMed ID: 4518348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myxomatosis and the rabbit.
    Ross J
    Br Vet J; 1972 Apr; 128(4):172-6. PubMed ID: 5033312
    [No Abstract]   [Full Text] [Related]  

  • 36. Innate resistance to myxomatosis in wild rabbits in England.
    Ross J; Sanders MF
    J Hyg (Lond); 1977 Dec; 79(3):411-5. PubMed ID: 270526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The development of genetic resistance to myxomatosis in wild rabbits in Britain.
    Ross J; Sanders MF
    J Hyg (Lond); 1984 Jun; 92(3):255-61. PubMed ID: 6736637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parallel adaptation of rabbit populations to myxoma virus.
    Alves JM; Carneiro M; Cheng JY; Lemos de Matos A; Rahman MM; Loog L; Campos PF; Wales N; Eriksson A; Manica A; Strive T; Graham SC; Afonso S; Bell DJ; Belmont L; Day JP; Fuller SJ; Marchandeau S; Palmer WJ; Queney G; Surridge AK; Vieira FG; McFadden G; Nielsen R; Gilbert MTP; Esteves PJ; Ferrand N; Jiggins FM
    Science; 2019 Mar; 363(6433):1319-1326. PubMed ID: 30765607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits.
    Mossman K; Nation P; Macen J; Garbutt M; Lucas A; McFadden G
    Virology; 1996 Jan; 215(1):17-30. PubMed ID: 8553583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Possible interaction between myxomatosis and calicivirosis related to rabbit haemorrhagic disease affecting the European rabbit.
    Marchandeau S; Bertagnoli S; Peralta B; Boucraut-Baralon C; Letty J; Reitz F
    Vet Rec; 2004 Nov; 155(19):589-92. PubMed ID: 15573951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.